State Key Laboratory of Marine Food Processing & Safety Control, College of Food Science and Engineering, Ocean University of China, No.1299, Sansha Road, Qingdao, Shandong Province, 266404, P.R. China.
Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao, 266237, P.R. China.
Food Funct. 2024 Sep 16;15(18):9298-9314. doi: 10.1039/d4fo02609h.
High Fischer ratio oligopeptides derived from Antarctic krill (HFOPs-AK) were screened, and their hepatoprotective effects and potential mechanisms were investigated. Herein, HFOPs-AK, with a Fischer ratio of 29 g/g (40.22 mol/mol) (MW < 1000 Da), were prepared two-step enzymatic hydrolysis using chymotrypsin and flavourzyme and aromatic amino acid removal. Seventy-eight characteristic peptides were identified from HFOPs-AK through UHPLC-Q/TOF, with peptides containing Leu, Val, or Ile accounting for 79%. High hepatoprotective peptides were purified using GFC and RP-HPLC and identified as SDELGW and LLGWDDM. Furthermore, a murine model of acute liver injury induced by alcohol was successfully established. It was demonstrated that the oral administration of HFOPs-AK (800 mg per kg bw per d) remarkably increased the contents of ADH and ALDH compared with the model group, reaching 3.40 and 5.10 U mg prot, respectively. Further, it was revealed that HFOPs-AK could effectively mitigate hepatic oxidative stress by increasing the levels of GSH-Px ( < 0.01) and decreasing the level of MDA ( < 0.05). Additionally, HFOPs-AK (800 mg per kg bw per d) attenuated liver inflammation by down-regulating the mRNA levels of TNF-α, IL-1β, and IL-6 by 40.45%, 38.48%, and 35.83%, respectively. Therefore, HFOPs-AK may have the potential as a new nutritional supplement for the treatment of alcoholic liver injury.
筛选出高 Fischer 比南极磷虾寡肽(HFOPs-AK),研究其对肝的保护作用及潜在机制。采用两步酶解法(胰蛋白酶和风味蛋白酶)和芳香族氨基酸去除法,制备 Fischer 比为 29 g/g(40.22 mol/mol)(MW<1000 Da)的 HFOPs-AK。通过 UHPLC-Q/TOF 鉴定出 78 种特征肽,HFOPs-AK 中含有亮氨酸、缬氨酸或异亮氨酸的肽占 79%。采用凝胶过滤色谱和反相高效液相色谱对高肝保护肽进行分离纯化,鉴定出 SDELGW 和 LLGWDDM 两种肽。此外,成功建立了酒精诱导的急性肝损伤小鼠模型。结果表明,与模型组相比,HFOPs-AK(800mg/kg bw/d)灌胃给药可显著提高 ADH 和 ALDH 含量,分别达到 3.40 和 5.10 U/mg prot。进一步研究表明,HFOPs-AK 可通过提高 GSH-Px 水平(<0.01)和降低 MDA 水平(<0.05),有效减轻肝氧化应激。此外,HFOPs-AK(800mg/kg bw/d)可通过下调 TNF-α、IL-1β 和 IL-6 的 mRNA 水平分别达 40.45%、38.48%和 35.83%,从而减轻肝炎症。因此,HFOPs-AK 可能具有作为治疗酒精性肝损伤的新型营养补充剂的潜力。